Arkema stock steadies as Q2 2026 EBITDA rises and short interest falls
Published on 08/13/2026 at 14:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Arkema SA (FR0010313833) stock is trading in the low €60s on Euronext Paris on August 13, 2026, with the shares quoted at €62.10 and down 0.40% at 2:05 p.m. local time as investors digest stronger second-quarter 2026 earnings and a confirmation of full-year guidance.
Per a same-day French market overview updated at 2:05 p.m. on August 13, 2026, Arkema is changing hands at €62.10 on Euronext Paris, having traded between an intraday high of €62.40 and a low of €61.55 as the broader CAC 40 holds modest gains.
Q2 2026 earnings show EBITDA growth and guidance confirmation
A detailed earnings summary published on July 30, 2026 reports that Arkema's EBITDA for the second quarter of 2026 increased by 7.4% year over year to €391 million, reflecting a more robust profitability profile than in the first quarter of the year.
The same Q2 2026 update notes that the company confirmed its full-year 2026 financial guidance, a signal that management sees the EBITDA momentum as consistent with previously stated targets despite a mixed macroeconomic backdrop for specialty chemicals.
For investors, the 7.4% rise in Q2 2026 EBITDA to €391 million versus the prior-year quarter points to improved operating efficiency and pricing power, especially after a weaker start to 2026, and helps underpin confidence in the reaffirmed guidance.
Short interest in US-listed shares drops sharply
On the US over-the-counter market, a same-day research alert on Arkema's American depositary shares (ticker ARKAY) shows that short interest fell substantially in July 2026, with total reported shorted shares declining from 1,729 on July 15, 2026 to 418 on July 31, 2026.
That July 2026 data implies a 75.8% reduction in short positions over the second half of the month and leaves just 0.0% of the US-listed float sold short, based on an average daily volume of 2,816 shares and a current days-to-cover ratio of 0.1 days.
The same alert cites a last-traded ARKAY price of $71.81 on the most recent session used for the snapshot and a market capitalization of $5.46 billion, plus a 52-week range for the ADR between a low of $56.28 and a high of $79.36.
Analyst sentiment and valuation backdrop
The short-interest figures sit against a cautious analyst backdrop, with compiled coverage data indicating that Arkema currently carries an overall Reduce consensus rating across its US-listed shares.
Market valuation tools referencing the Paris-listed line show Arkema shares trading around the low-€60 level as of August 12, 2026, with a recent indicative closing price of €62.90 and a daily gain of 2.19% on that session, placing the stock modestly above key technical support levels highlighted in recent French trading commentary.
Earlier technical notes from late June and June 18, 2026 emphasized that Arkema shares had broken below support zones near €57.20 and €57.25 in periods of market weakness, so the present €62 handle suggests a recovery of 8-9% versus those previously stressed support levels.
Operational profile and recent strategic move
Arkema describes itself as a global specialty chemicals and advanced materials company headquartered in Colombes, France, providing high-performance materials that enhance durability, thermal and chemical resistance, and environmental performance across a broad range of industries.
According to a June 23, 2026 update on the company, Arkema has recently expanded its production capacity for polyvinylidene fluoride (PVDF) at its Calvert City site in Kentucky, increasing capacity by 15% through a €20 million investment to support growing demand in energy storage and high-performance coatings.
A separate corporate governance announcement dated May 29, 2026 reports the appointment of Laurent Tellier as chief operating officer effective July 1, 2026, adding an additional layer of leadership continuity as Arkema executes its strategy in adhesives, advanced materials, and coating solutions.
Representative product: advanced PVDF materials
One representative Arkema product line is its advanced PVDF materials, which are used in lithium-ion battery binders, high-performance membranes, and industrial coatings requiring strong chemical resistance and durability.
These PVDF solutions aim to combine mechanical strength and thermal stability with the ability to support demanding applications in electric vehicles, renewable energy, and water treatment, making them a core part of Arkema's push toward higher-value specialty materials.
Arkema stock in the current market
As of August 13, 2026, Arkema shares on Euronext Paris trade at €62.10, down 0.40% on the day at 2:05 p.m. local time, while the US over-the-counter ARKAY line most recently showed a price of $71.81 within a 52-week band of $56.28 to $79.36, giving investors exposure to the specialty chemicals group in both European and US markets.
Fact box
Company: Arkema SA
ISIN: FR0010313833
Ticker: AKE
Exchange: Euronext Paris
Price (as of August 13, 2026, 2:05 p.m. local time): €62.10
Market cap: $5.46 billion (as of the latest ARKAY snapshot)
Sector / Industry: Chemicals / Specialty materials
Index membership: CAC 40
